SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (533)8/10/2002 7:02:47 PM
From: scaram(o)uche  Read Replies (1) of 724
 
Patent Number: US6387879
Publication date: 2002-05-14
Inventor(s): MANDECKI WLODEK S (US); BLUME ARTHUR J (US); BRISSETTE RENEE (US); CARCAMO JUAN (US); TANG PAULINE M (US)
Applicant(s): DGI BIOTECHNOLOGIES INC (US)
Requested Patent: US6387879
Application Number: US19970990888 19971215
Priority Number(s): US19970990888 19971215

--------------------------------------------------------------------------------
Abstract
--------------------------------------------------------------------------------

The present invention provides peptides that bind to the active site of the growth hormone receptor. The present invention also provides methods of using these peptides to identify small organic molecules, which are novel agonists or antagonists of the growth hormone receptor. In addition, the present invention provides kits and therapeutic compositions comprising the peptides that bind to growth hormone receptor
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News